Nevin Hammam Selected Research

Nevin Hammam Research Topics

Disease

9	Rheumatoid Arthritis 03/2024 - 11/2017
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2023 - 09/2020
3	Inflammation (Inflammations) 02/2022 - 01/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2024 - 01/2023
2	COVID-19 01/2022 - 01/2021
2	Vasculitis (Vasculitides) 11/2021 - 08/2021
2	Rheumatic Diseases (Rheumatism) 09/2021 - 01/2021
1	Fibromyalgia (Fibrositis) 03/2024
1	Skin Manifestations 06/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Gout 01/2023
1	Insulin Resistance 01/2023
1	Obesity 01/2023
1	Thrombocytosis (Thrombocythemia) 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2023
1	Fatigue 01/2022
1	Dizziness (Lightheadedness) 01/2022
1	Sarcoidosis (Schaumann Disease) 01/2022
1	Myalgia 01/2022
1	Low Back Pain (Lumbago) 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Chills 01/2022
1	Headache (Headaches) 01/2022
1	Fever (Fevers) 01/2022
1	Infections 01/2022
1	Tuberculosis (Tuberculoses) 12/2020
1	Arthritis (Polyarthritis) 09/2020
1	Necrosis 01/2019
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2019
1	Systemic Scleroderma (Systemic Sclerosis) 03/2018
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 06/2023 - 01/2018
3	SteroidsIBA 03/2024 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 03/2024 - 07/2020
2	AutoantibodiesIBA 03/2024 - 05/2021
2	GlucocorticoidsIBA 10/2022 - 01/2022
2	Methotrexate (Mexate)FDA LinkGeneric 08/2022 - 08/2019
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 02/2022 - 11/2020
2	VaccinesIBA 01/2022 - 01/2021
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2019 - 01/2019
1	ametantrone (HAQ)IBA 03/2024
1	Anti-Citrullinated Protein AntibodiesIBA 03/2024
1	Rheumatoid FactorIBA 03/2024
1	PTX3 proteinIBA 06/2023
1	Indicators and Reagents (Reagents)IBA 06/2023
1	SugarsIBA 01/2023
1	Uric Acid (Urate)IBA 01/2023
1	belimumabIBA 10/2022
1	Infliximab (Remicade)FDA Link 08/2022
1	Tumor Necrosis Factor InhibitorsIBA 08/2022
1	golimumab FDA Link 08/2022
1	Silk FDA Link 11/2021
1	Blood Group Antigens (Blood Groups)IBA 09/2021
1	cyclic citrullinated peptideIBA 09/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 08/2021
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 05/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2020
1	collagen type I trimeric cross-linked peptideIBA 01/2020
1	Cartilage Oligomeric Matrix ProteinIBA 01/2020
1	Collagen Type II (Type II Collagen)IBA 01/2020
1	Antirheumatic Agents (DMARD)IBA 08/2019
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 08/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Oxidants (Oxidizing Agents)IBA 12/2018
1	Toll-Like Receptor 9IBA 03/2018
1	CytokinesIBA 11/2017
1	Tobacco Smoke Pollution (Passive Smoking)IBA 11/2017

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2022
1	Activities of Daily Living (ADL) 01/2018